Entries tagged "Elan Corp. plc"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Elan Corp. plc."

9 result(s) displayed (1 - 9 of 9)

Stage set for showdown over Elan

Eyes are on Royal Pharma as it weighs its best and final offer. Continue reading

Posted on April 19, 2013 9:05 AM

Royalty Pharma makes $6.5B unsolicited bid for Elan

The pharmaceuticals investor discloses its bid plan after hitting a roadblock in talks with the Irish drugmaker. Continue reading

Posted on February 25, 2013 8:48 AM

Elan outlines how it will use Tysabri sale proceeds

The Irish drugmaker will take the opportunity after the $3.25 billion sale of the multiple sclerosis treatment to make acquisitions, buy shares and refinance its debt. Continue reading

Posted on February 22, 2013 4:27 PM

Biogen buys out Tysabri rights for $3.3B

Elan cedes control of the blockbuster multiple sclerosis drug, its sole revenue producer, in an attempt to pursue a new strategic direction through acquisitions. Continue reading

Posted on February 6, 2013 11:23 AM

After drug's collapse, all eyes on Elan

The pharmaceutical company's share price is buoyed by takeover speculation after its Alzheimer's compound fails a clinical trial Continue reading

Posted on August 8, 2012 9:08 AM

Biotech milestones, blockbusters and orphans

In 2011, risk sharing returned to dealmaking in the sector as overconfidence left the market. Continue reading

Posted on December 9, 2011 12:00 PM

Deal diary: May 23-June 12, 2011

Simpson Thacher and Sullivan & Cromwell change places for Microsoft, Hertz adds Cravath, Ondra Partners structures Elan, and a new Dewey & LeBoeuf partner jumps into the Silicon Valley fray. Continue reading

Posted on May 20, 2011 12:30 PM

Elan gets a haircut

Johnson & Johnson takes advantage after a court ruling leaves Elan vulnerable. Continue reading

Posted on September 18, 2009 12:07 PM

Elan does a jig with Citi to land J&J deal

A public announcement that it had hired Citigroup to seek strategic alternatives helped Irish drugmaker Elan Corp. plc spark the process that led to its $1.5 billion deal with J&J. Continue reading

Posted on July 17, 2009 3:18 PM

Movable Type search results powered by Fast Search